Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The Cardiology Devices market in Lesotho is experiencing steady growth due to increasing customer preferences for advanced medical devices and the rising prevalence of cardiovascular diseases.
Customer preferences: Customers in Lesotho are increasingly demanding advanced cardiology devices that offer accurate diagnosis and effective treatment options. They prefer devices that are technologically advanced, portable, and easy to use. Additionally, there is a growing preference for minimally invasive procedures, which has led to an increased demand for catheters and stents.
Trends in the market: One of the key trends in the Cardiology Devices market in Lesotho is the adoption of telemedicine. This trend has gained traction due to the limited availability of specialized healthcare facilities in remote areas of the country. Telemedicine allows patients to consult with cardiologists remotely, reducing the need for travel and improving access to specialized care. This has led to an increased demand for remote monitoring devices and telecardiology services. Another trend in the market is the increasing focus on preventive cardiology. Healthcare providers in Lesotho are emphasizing the importance of early detection and prevention of cardiovascular diseases. This has resulted in a growing demand for diagnostic devices such as ECG machines, stress test systems, and Holter monitors. Additionally, there is a rising interest in lifestyle modification programs and cardiac rehabilitation services.
Local special circumstances: Lesotho faces unique challenges in the Cardiology Devices market due to its geographical location and limited healthcare infrastructure. The country is landlocked, which makes it difficult to import medical devices and equipment. This has led to a reliance on neighboring countries for the supply of cardiology devices. Additionally, the limited number of specialized healthcare facilities in Lesotho has resulted in a lack of trained healthcare professionals, which further affects the adoption of advanced cardiology devices.
Underlying macroeconomic factors: The growth of the Cardiology Devices market in Lesotho is also influenced by underlying macroeconomic factors. The country has been experiencing economic growth, which has led to an increase in disposable income and improved healthcare expenditure. This has positively impacted the affordability and accessibility of cardiology devices for the population. Additionally, the government of Lesotho has been investing in the improvement of healthcare infrastructure, which has further supported the growth of the market. In conclusion, the Cardiology Devices market in Lesotho is witnessing steady growth due to increasing customer preferences for advanced medical devices, the adoption of telemedicine, and the focus on preventive cardiology. However, the market is also affected by local special circumstances such as limited healthcare infrastructure and reliance on neighboring countries for the supply of devices. The underlying macroeconomic factors, including economic growth and government investments in healthcare, have also contributed to the growth of the market.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights